The Insulin Delivery Devices Market Size accounted for USD 16.7 Billion in 2022 and is estimated to achieve a market size of USD 40.2 Billion by 2032 growing at a CAGR of 9.3% from 2023 to 2032.
Insulin Delivery Devices Market Highlights
- Global insulin delivery devices market revenue is poised to garner USD 40.2 billion by 2032 with a CAGR of 9.3% from 2023 to 2032
- North America insulin delivery devices market value occupied around USD 6.2 billion in 2022
- Asia-Pacific insulin delivery devices market growth will record a CAGR of more than 10.6% from 2023 to 2032
- Among type, the insulin pens sub-segment generated more than USD 6 billion revenue in 2022
- Based on end use, the homecare sub-segment generated around 48% market share in 2022
- Emerging markets presenting untapped growth potential for insulin delivery device manufacturers is a popular insulin delivery devices market trend that fuels the industry demand
![Insulin Delivery Devices Market Size Insulin Delivery Devices Market Dynamics](reportimages/Main-Infographics_Global-Insulin-Delivery-Devices-Market,-2023-2032---Copy.jpg)
Insulin delivery devices are essential for administering insulin to patients with Type 1 and Type 2 diabetes. Insulin plays a crucial role in diabetes treatment by facilitating the transfer of glucose from the bloodstream into the muscles. Unlike pills or liquids, insulin cannot be ingested orally as it would be digested and not reach the bloodstream. Instead, it is typically injected or infused into the fatty tissues under the skin. Various types of devices are used for insulin delivery, including insulin syringes, insulin pens, insulin jet injectors, insulin pumps, and insulin inhalers. Insulin syringes allow for direct injection of insulin using a needle. Insulin pens come in disposable and reusable forms, featuring short and thin designs. Insulin pumps are available in tethered and patch forms; tethered pumps are attached to the body with a small tube, while patch pumps have no or very short tubes. Additionally, insulin can be inhaled using insulin inhalers, with the dose entering the lungs and subsequently being absorbed into the bloodstream. Both external and implantable insulin options are available in the market.
Global Insulin Delivery Devices Market Dynamics
Market Drivers
- Increasing prevalence of diabetes worldwide
- Technological advancements in insulin delivery devices
- Growing awareness about diabetes management and treatment
- Rising demand for minimally invasive insulin delivery solutions
Market Restraints
- Stringent regulatory requirements for insulin delivery devices
- High cost associated with advanced insulin delivery technologies
- Limited accessibility to insulin delivery devices in developing regions
Market Opportunities
- Expanding market penetration through strategic collaborations and partnerships
- Development of personalized insulin delivery solutions
- Rising adoption of insulin pumps and continuous glucose monitoring systems
Insulin Delivery Devices Market Report Coverage
Market |
Insulin Delivery Devices Market
|
Insulin Delivery Devices Market Size 2022 |
USD 16.7 Billion |
Insulin Delivery Devices Market Forecast 2032 |
USD 40.2 Billion
|
Insulin Delivery Devices Market CAGR During 2023 - 2032 |
9.3% |
Insulin Delivery Devices Market Analysis Period |
2020 - 2032 |
Insulin Delivery Devices Market Base Year
|
2022 |
Insulin Delivery Devices Market Forecast Data |
2023 - 2032 |
Segments Covered |
By Type, By Distribution Channel, By End Use, And By Geography
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Key Companies Profiled |
Ypsomed AG, Novo Nordisk A/S, Wockhardt Ltd., Medtronic, F. Hoffmann-La Roche, Ltd., Abbott Laboratories, Sanofi, Eli Lilly and Company, Biocon Ltd., and Becton, Dickinson and Company.
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
Insulin Delivery Devices Market Insights
The tremendous increase in the worldwide diabetes population in recent years has been the key driver of the insulin device industry. This increase is supported by a number of variables, including rising discretionary income and the availability of favourable reimbursement rules, which all contribute to market expansion. Moreover, increased consumer knowledge of the availability of various insulin delivery devices plays a vital role in the market's rising demand. Furthermore, the continuous lack of a definite and effective diabetes treatment highlights the critical need for insulin therapy improvement, which will drive market expansion even further. Despite continuing medical advancements, diabetes remains a chronic disorder that requires long-term treatment, emphasising the need of insulin delivery systems. As a result, the industry is still expanding as healthcare practitioners and consumers look for new ways to improve diabetes control and quality of life.
The availability of oral insulin has a substantial impact on the insulin delivery device business. Despite its potential appeal to patients because to its non-invasive nature, oral insulin confronts obstacles that prevent widespread adoption. These issues include lower bioavailability and efficacy as a result of enzymatic breakdown in the digestive system, as well as varying absorption rates. Furthermore, greater dosages are required to elicit therapeutic benefits, which complicates its utilisation. As a result, conventional insulin administration methods such as syringes, pens, pumps, and inhalers remain popular among both healthcare practitioners and patients. However, technical improvements in insulin delivery devices provide promising answers to these difficulties, potentially minimising the influence of oral insulin on market growth and generating demand for novel delivery methods.![Insulin Delivery Devices Market - Acumen Research and Consulting Insulin Delivery Devices Market Growth 2023 - 2032](reportimages/Discounted-Price-Template-1.jpg)
Insulin Delivery Devices Market Segmentation
The worldwide market for insulin delivery devices is split based on type, distribution channel, end use, and geography.
Insulin Delivery Device Market By Type
- Insulin Syringe
- Insulin Pens
- Insulin Jet Injectors
- Insulin Pumps
- Insulin Needles
- Insulin Inhalers
According to insulin delivery devices industry analysis, the insulin pen segment dominates the market by type, holding the maximum share. This segment has been experiencing significant growth primarily due to its presence in the market since the late 1980s. The availability of pens in both disposable and reusable forms further supports this growth. According to the ADA, diabetes patients express greater satisfaction with insulin pens compared to the vial and syringe technique, particularly with prefilled disposable pens. Other benefits associated with insulin pen usage include ease of use for both children and the elderly, portability, and convenience, as well as the presence of small needles to minimize fear and pain.
Insulin Delivery Device Market By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Sales
- Diabetes Clinics & Centers
Hospital pharmacies are the main distribution route and it will grow throughout the insulin delivery devices industry forecast period. This dominance is due to a variety of variables. For starters, hospital pharmacies act as important centres for healthcare services, providing patients with a wide choice of medicinal supplies, including insulin delivery devices, while under expert supervision. Furthermore, hospitals frequently serve a broad patient population, including individuals with acute and chronic illnesses like diabetes, necessitating the availability of a variety of insulin administration methods. Moreover, hospital pharmacists maintain close ties with healthcare practitioners, which allows for easy communication and collaboration when prescribing and distributing insulin devices. Overall, hospital pharmacies are the preferred distribution channel for insulin delivery devices due to their extensive services, accessibility, and competence, which contributes greatly to their market dominance.
Insulin Delivery Device Market By End-Use
- Hospitals
- Clinics
- Ambulatory Care Centers
- Homecare
Several significant factors contribute to the homecare sector becoming the largest end-use category in the insulin delivery devices market. To begin, there is an increasing tendency towards patient-centered treatment, which encourages diabetics to control their illness from the comfort of their own homes. Homecare settings provide patients with greater convenience, autonomy, and flexibility in managing their insulin administration, leading to increased usage of insulin delivery devices. On other hand, technical improvements have made equipment more user-friendly and accessible for self-administration, boosting demand in the homecare sector. Furthermore, with the global prevalence of diabetes increasing, homecare offers a cost-effective approach for long-term disease treatment, lessening the strain on healthcare institutions. Overall, the homecare sector's emphasis on patient empowerment and convenience makes it the largest and fastest-growing category in the insulin delivery device market.
Insulin Delivery Devices Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
![Insulin Delivery Devices Market Share Insulin Delivery Devices Market Drivers](reportimages/Regional-Infographics_Global-Insulin-Delivery-Devices-Market,-2023---2032---Copy.jpg)
Insulin Delivery Devices Market Regional Analysis
In 2022, North America accounted for the major shares in the regional market and it is also expected to continue with the dominance over the insulin delivery devices market forecast period from 2023 to 2032 owing to the increasing number of diabetes patients. The changing lifestyle and unhealthy eating habits are contributing to the growing number of diabetes cases in the region. In addition, favorable government policies, programs, and actions are further supporting the regional market growth.
Asia-Pacific has emerged as the fastest-growing region in the insulin delivery devices market, owing to a number of factors. To begin, the region is rapidly urbanizing and industrializing, resulting in substantial lifestyle changes such as sedentary lifestyles and bad food habits, all of which contribute to the increased incidence of diabetes. Furthermore, the Asia-Pacific region's demand for insulin delivery devices is being driven by improvements in healthcare infrastructure, higher disposable incomes, and increased access to healthcare services. Furthermore, aggressive government activities, such as awareness campaigns and subsidized healthcare programs, are fueling market expansion. As a result, Asia-Pacific has significant development prospects for insulin delivery device makers, ranking as the market's fastest-growing region.
Insulin Delivery Devices Market Players
Some of the top insulin delivery devices companies offered in our report include Ypsomed AG, Novo Nordisk A/S, Wockhardt Ltd., Medtronic, F. Hoffmann-La Roche, Ltd., Abbott Laboratories, Sanofi, Eli Lilly and Company, Biocon Ltd., and Becton, Dickinson and Company.
CHAPTER 1. Industry Overview of Insulin Delivery Devices Market
1.1. Definition and Scope
1.1.1. Definition of Insulin Delivery Devices
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Insulin Delivery Devices Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Insulin Delivery Devices Market By Type
1.2.3. Insulin Delivery Devices Market By Distribution Channel
1.2.4. Insulin Delivery Devices Market By End Use
1.2.5. Insulin Delivery Devices Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Insulin Delivery Devices Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Insulin Delivery Devices Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Insulin Delivery Devices Market By Type
5.1. Introduction
5.2. Insulin Delivery Devices Revenue By Type
5.2.1. Insulin Delivery Devices Revenue (USD Million) and Forecast, By Type, 2020-2032
5.2.2. Insulin Syringe
5.2.2.1. Insulin Syringe Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Insulin Pens
5.2.3.1. Insulin Pens Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4. Insulin Jet Injectors
5.2.4.1. Insulin Jet Injectors Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5. Insulin Pumps
5.2.5.1. Insulin Pumps Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.6. Insulin Needles
5.2.6.1. Insulin Needles Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.7. Insulin Inhalers
5.2.7.1. Insulin Inhalers Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Insulin Delivery Devices Market By Distribution Channel
6.1. Introduction
6.2. Insulin Delivery Devices Revenue By Distribution Channel
6.2.1. Insulin Delivery Devices Revenue (USD Million) and Forecast, By Distribution Channel, 2020-2032
6.2.2. Hospital Pharmacies
6.2.2.1. Hospital Pharmacies Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Retail Pharmacies
6.2.3.1. Retail Pharmacies Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.4. Online Sales
6.2.4.1. Online Sales Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.5. Diabetes Clinics & Centers
6.2.5.1. Diabetes Clinics & Centers Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. Insulin Delivery Devices Market By End Use
7.1. Introduction
7.2. Insulin Delivery Devices Revenue By End Use
7.2.1. Insulin Delivery Devices Revenue (USD Million) and Forecast, By End Use, 2020-2032
7.2.2. Hospitals
7.2.2.1. Hospitals Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.3. Clinics
7.2.3.1. Clinics Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.4. Ambulatory Care Centers
7.2.4.1. Ambulatory Care Centers Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.5. Homecare
7.2.5.1. Homecare Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Insulin Delivery Devices Market By Country
8.1. North America Insulin Delivery Devices Market Overview
8.2. U.S.
8.2.1. U.S. Insulin Delivery Devices Revenue (USD Million) and Forecast By Type, 2020-2032
8.2.2. U.S. Insulin Delivery Devices Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
8.2.3. U.S. Insulin Delivery Devices Revenue (USD Million) and Forecast By End Use, 2020-2032
8.3. Canada
8.3.1. Canada Insulin Delivery Devices Revenue (USD Million) and Forecast By Type, 2020-2032
8.3.2. Canada Insulin Delivery Devices Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
8.3.3. Canada Insulin Delivery Devices Revenue (USD Million) and Forecast By End Use, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Insulin Delivery Devices Market By Country
9.1. Europe Insulin Delivery Devices Market Overview
9.2. U.K.
9.2.1. U.K. Insulin Delivery Devices Revenue (USD Million) and Forecast By Type, 2020-2032
9.2.2. U.K. Insulin Delivery Devices Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
9.2.3. U.K. Insulin Delivery Devices Revenue (USD Million) and Forecast By End Use, 2020-2032
9.3. Germany
9.3.1. Germany Insulin Delivery Devices Revenue (USD Million) and Forecast By Type, 2020-2032
9.3.2. Germany Insulin Delivery Devices Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
9.3.3. Germany Insulin Delivery Devices Revenue (USD Million) and Forecast By End Use, 2020-2032
9.4. France
9.4.1. France Insulin Delivery Devices Revenue (USD Million) and Forecast By Type, 2020-2032
9.4.2. France Insulin Delivery Devices Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
9.4.3. France Insulin Delivery Devices Revenue (USD Million) and Forecast By End Use, 2020-2032
9.5. Spain
9.5.1. Spain Insulin Delivery Devices Revenue (USD Million) and Forecast By Type, 2020-2032
9.5.2. Spain Insulin Delivery Devices Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
9.5.3. Spain Insulin Delivery Devices Revenue (USD Million) and Forecast By End Use, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Insulin Delivery Devices Revenue (USD Million) and Forecast By Type, 2020-2032
9.6.2. Rest of Europe Insulin Delivery Devices Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
9.6.3. Rest of Europe Insulin Delivery Devices Revenue (USD Million) and Forecast By End Use, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Insulin Delivery Devices Market By Country
10.1. Asia Pacific Insulin Delivery Devices Market Overview
10.2. China
10.2.1. China Insulin Delivery Devices Revenue (USD Million) and Forecast By Type, 2020-2032
10.2.2. China Insulin Delivery Devices Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.2.3. China Insulin Delivery Devices Revenue (USD Million) and Forecast By End Use, 2020-2032
10.3. Japan
10.3.1. Japan Insulin Delivery Devices Revenue (USD Million) and Forecast By Type, 2020-2032
10.3.2. Japan Insulin Delivery Devices Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.3.3. Japan Insulin Delivery Devices Revenue (USD Million) and Forecast By End Use, 2020-2032
10.4. India
10.4.1. India Insulin Delivery Devices Revenue (USD Million) and Forecast By Type, 2020-2032
10.4.2. India Insulin Delivery Devices Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.4.3. India Insulin Delivery Devices Revenue (USD Million) and Forecast By End Use, 2020-2032
10.5. Australia
10.5.1. Australia Insulin Delivery Devices Revenue (USD Million) and Forecast By Type, 2020-2032
10.5.2. Australia Insulin Delivery Devices Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.5.3. Australia Insulin Delivery Devices Revenue (USD Million) and Forecast By End Use, 2020-2032
10.6. South Korea
10.6.1. South Korea Insulin Delivery Devices Revenue (USD Million) and Forecast By Type, 2020-2032
10.6.2. South Korea Insulin Delivery Devices Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.6.3. South Korea Insulin Delivery Devices Revenue (USD Million) and Forecast By End Use, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Insulin Delivery Devices Revenue (USD Million) and Forecast By Type, 2020-2032
10.7.2. Rest of Asia-Pacific Insulin Delivery Devices Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.7.3. Rest of Asia-Pacific Insulin Delivery Devices Revenue (USD Million) and Forecast By End Use, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Insulin Delivery Devices Market By Country
11.1. Latin America Insulin Delivery Devices Market Overview
11.2. Brazil
11.2.1. Brazil Insulin Delivery Devices Revenue (USD Million) and Forecast By Type, 2020-2032
11.2.2. Brazil Insulin Delivery Devices Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.2.3. Brazil Insulin Delivery Devices Revenue (USD Million) and Forecast By End Use, 2020-2032
11.3. Mexico
11.3.1. Mexico Insulin Delivery Devices Revenue (USD Million) and Forecast By Type, 2020-2032
11.3.2. Mexico Insulin Delivery Devices Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.3.3. Mexico Insulin Delivery Devices Revenue (USD Million) and Forecast By End Use, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Insulin Delivery Devices Revenue (USD Million) and Forecast By Type, 2020-2032
11.4.2. Rest of Latin America Insulin Delivery Devices Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.4.3. Rest of Latin America Insulin Delivery Devices Revenue (USD Million) and Forecast By End Use, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Insulin Delivery Devices Market By Country
12.1. Middle East & Africa Insulin Delivery Devices Market Overview
12.2. GCC
12.2.1. GCC Insulin Delivery Devices Revenue (USD Million) and Forecast By Type, 2020-2032
12.2.2. GCC Insulin Delivery Devices Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
12.2.3. GCC Insulin Delivery Devices Revenue (USD Million) and Forecast By End Use, 2020-2032
12.3. South Africa
12.3.1. South Africa Insulin Delivery Devices Revenue (USD Million) and Forecast By Type, 2020-2032
12.3.2. South Africa Insulin Delivery Devices Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
12.3.3. South Africa Insulin Delivery Devices Revenue (USD Million) and Forecast By End Use, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Insulin Delivery Devices Revenue (USD Million) and Forecast By Type, 2020-2032
12.4.2. Rest of Middle East & Africa Insulin Delivery Devices Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
12.4.3. Rest of Middle East & Africa Insulin Delivery Devices Revenue (USD Million) and Forecast By End Use, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Insulin Delivery Devices Market
13.1. Insulin Delivery Devices Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Insulin Delivery Devices Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Ypsomed AG
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Million), 2022
14.1.3.2. Ypsomed AG 2022 Insulin Delivery Devices Business Regional Distribution
14.1.4. Product /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Novo Nordisk A/S
14.3. Wockhardt Ltd.
14.4. Medtronic
14.5. F. Hoffmann-La Roche, Ltd.
14.6. Abbott Laboratories
14.7. Sanofi
14.8. Eli Lilly and Company
14.9. Biocon Ltd.
14.10. Becton, Dickinson and Company